Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin

被引:45
|
作者
Yao, L
Pike, SE
Pittaluga, S
Cherney, B
Gupta, G
Jaffe, ES
Tosato, G
机构
[1] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Hematopathol Sect, Pathol Lab, NIH, Bethesda, MD 20892 USA
[3] Ctr Biol Evaluat & Res, Rockville, MD USA
关键词
angiogenesis; calreticulin; chemokine; endothelium; IP-10;
D O I
10.1007/s00262-002-0294-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor growth depends upon an adequate supply of oxygen and nutrients achieved through angiogenesis and maintenance of an intact tumor vasculature. Therapy with individual agents that target new vessel formation or existing vessels has suppressed experimental tumor growth, but rarely resulted in the eradication of tumors. We therefore tested the combined anti-tumor activity of vasostatin and interferon-inducible protein-10 (IP-10), agents that differently target the tumor vasculature. Vasostatin, a selective and direct inhibitor of endothelial cell proliferation, significantly reduced Burkitt tumor growth and tumor vessel density. IP-10, an "angiotoxic" chemokine, caused vascular damage and focal necrosis in Burkitt tumors. When combined, vasostatin plus IP-10 reduced tumor growth more effectively than each agent alone, but complete tumor regression was not observed. Microscopically, these tumors displayed focal necrosis and reduction in vessel density. Combination therapy with the inhibitors of angiogenesis vasostatin and IP-10 is effective in reducing the rate of tumor growth but fails to induce tumor regression, suggesting that curative treatment may require supplemental drugs targeting directly the tumor cells.
引用
收藏
页码:358 / 366
页数:9
相关论文
共 50 条
  • [41] Effects of Acute Hypervolaemic Haemodilution on the Expression of Plasma Interferon-inducible Protein-10 and Bactericidal/Permeability-increasing Protein in Patients Undergoing Total Hip Replacement
    Tang, Q. F.
    Hao, Y. F.
    Qian, Y. N.
    Yang, J. J.
    Wang, Z. Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (05) : 1450 - 1456
  • [42] Interferon-inducible protein-10 (CXCL10/IP-10) and its receptor CXCR3 are hyperexpressed during acute rejection of renal allografts.
    Tatapudi, R
    Muthukumar, T
    Lozada, E
    Seetharamu, N
    Dadhania, D
    Ding, R
    Li, B
    Sharma, V
    Seshan, S
    Suthanthiran, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 420A - 420A
  • [43] Autophagy Induced by a Novel Triazol Derivative Promotes Angiogenesis Through Decreasing Interferon-Inducible Protein 10 Level in Vascular Endothelial Cells
    Meng, Ning
    Mu, Xin
    Gong, Yan
    Wang, Yan Hong
    Zhang, Juan
    Wang, Mao Hua
    Yang, Feng Ying
    Jiang, Cheng Shi
    Zhang, Hua
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (01) : 136 - 146
  • [44] Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients
    Ansell, Stephen M.
    Maurer, Matthew J.
    Ziesmer, Steven C.
    Slager, Susan L.
    Habermann, Thomas M.
    Link, Brian K.
    Witzig, Thomas E.
    Macon, William R.
    Dogan, Ahmet
    Cerhan, James R.
    Novak, Anne J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 865 - 869
  • [45] RECOMBINANT HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A CHEMOATTRACTANT FOR HUMAN MONOCYTES AND T-LYMPHOCYTES AND PROMOTES T-CELL ADHESION TO ENDOTHELIAL-CELLS
    TAUB, DD
    LLOYD, AR
    CONLON, K
    WANG, JM
    ORTALDO, JR
    HARADA, A
    MATSUSHIMA, K
    KELVIN, DJ
    OPPENHEIM, JJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06): : 1809 - 1814
  • [46] Serum Interferon-inducible Protein-10 is Associated with Replicative Status of Hepatitis D Virus, and Correlates with Hepatitis D RNA Levels, but does not Predict Treatment Outcome
    Hughes, Sarah A.
    Carey, Ivana
    Bruce, Matthew J.
    Horner, Mary
    Shang, Dazhuang
    Fletcher, Ian
    Suddlel, Abid
    Agarwal, Kosh
    Harrison, Phillip M.
    HEPATOLOGY, 2012, 56 : 1062A - 1063A
  • [47] Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth
    Sun, YS
    Finger, C
    Alvarez-Vallina, L
    Cichutek, K
    Buchholz, CJ
    CANCER GENE THERAPY, 2005, 12 (11) : 900 - 912
  • [48] Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth
    Yuansheng Sun
    Carsten Finger
    Luis Alvarez-Vallina
    Klaus Cichutek
    Christian J Buchholz
    Cancer Gene Therapy, 2005, 12 : 900 - 912
  • [49] Diagnostic values of soluble triggering receptor expressed on myeloid cells (sTREM-1) and interferon-inducible protein-10 (IP-10) for severe mycoplasma pneumoniae pneumonia in children
    Xu, Chang
    Luo, Li-Yan
    Wu, Bi-Chen
    Ding, Niu
    Jin, Shi-Jie
    Huang, Jian-Bao
    Chen, Yan-Ping
    CLINICS, 2024, 79
  • [50] B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis
    Nishikawa, Hiroki
    Enomoto, Hirayuki
    Iwata, Yoshinori
    Kishino, Kyohei
    Shimono, Yoshihiro
    Hasegawa, Kunihiro
    Nakano, Chikage
    Takata, Ryo
    Nishimura, Takashi
    Yoh, Kazunori
    Ishii, Akio
    Aizawa, Nobuhiro
    Sakai, Yoshiyuki
    Ikeda, Naoto
    Takashima, Tomoyuki
    Iijima, Hiroko
    Nishiguchi, Shuhei
    MEDICINE, 2016, 95 (12)